Prognostic value of SRSF2 mutations in patients with de novo myelodysplastic syndromes: A meta-analysis

BACKGROUND: The recent application of gene-sequencing technology has identified many new somatic mutations in patients with myelodysplastic syndromes (MDS). Among them, serine and arginine rich splicing factor 2 (SRSF2) mutations belonging to the RNA splicing pathway were of interest. Many studies h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xue, Zhan, Zhi, Naren, Duolan, Li, Jing, Yan, Tianyou, Gong, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617234/
https://www.ncbi.nlm.nih.gov/pubmed/28953917
http://dx.doi.org/10.1371/journal.pone.0185053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617234/
https://www.ncbi.nlm.nih.gov/pubmed/28953917
http://dx.doi.org/10.1371/journal.pone.0185053

Ejemplares similares